-

TCOM Investor Alert: Trip.com Group Limited Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Monopoly Enforcement Risk: Levi & Korsinsky

Notice to Pension Funds, Asset Managers, and Fiduciaries

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Trip.com Group Limited (NASDAQ: TCOM) during the period April 30, 2024 through January 13, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

TCOM ADSs lost $14.38 per share over two trading sessions in January 2026, a combined decline of approximately 19%, after China's State Administration for Market Regulation publicly accused the company of abusing its market position and engaging in monopolistic practices. The Court has set May 11, 2026 as the deadline to apply for lead plaintiff appointment.

Fiduciary Obligations and Recovery Options

Institutional holders with fiduciary duties to beneficiaries should consider the following:

  • Pension funds, endowments, and asset managers that acquired TCOM ADSs during the Class Period may have standing to seek appointment as lead plaintiff, which provides direct oversight of litigation strategy and settlement negotiations
  • Fiduciaries have an obligation to evaluate whether participation in securities recovery actions is in the best interest of plan participants and beneficiaries
  • Lead plaintiff appointment carries no out-of-pocket cost; counsel fees are paid only from any recovery, subject to court approval
  • Institutional investors with the largest financial interest in the relief sought typically receive preference under the PSLRA's lead plaintiff selection process
  • Failure to evaluate class action recovery opportunities may itself raise fiduciary questions for plan administrators

Portfolio Impact Assessment

The securities action alleges that Trip.com's annual filings framed anti-monopoly enforcement as a hypothetical risk, using language such as "could" be adversely affected, while the company's dominant market position and history of acquisitions, including the 2015 Qunar transaction, had already drawn regulatory attention. Chinese regulators in Guizhou and Zhengzhou had summoned online travel platforms, including Trip.com, over antitrust concerns months before the January 2026 probe became public. Portfolio managers who sized TCOM positions based on disclosed risk profiles may find those profiles were materially incomplete.

Contact us for institutional recovery options or call (212) 363-7500.

"Institutional investors play a critical role in securities class actions. Their participation strengthens the litigation process and helps ensure that recovery efforts reflect the full scope of harm suffered by all shareholders who relied on the company's public disclosures." -- Joseph E. Levi, Esq.

Case Summary

The action, filed in the U.S. District Court for the Eastern District of New York, asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 on behalf of purchasers of TCOM securities during the Class Period.

INSTITUTIONAL INVESTOR REPRESENTATION -- Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NASDAQ:TCOM

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

AVAV Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in AeroVironment, Inc. Securities Lawsuit - Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP tracks Wall Street analyst opinion on AeroVironment, Inc. (NASDAQ: AVAV) following a securities class action filed on behalf of investors who purchased AVAV securities between June 25, 2025 and March 10, 2026. Find out if you qualify to recover losses from AVAV's decline or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Raymond James cut AeroVironment from Strong Buy to Underperform in a single move on March 2, 202...

SES Shareholder Alert: SES AI Corporation Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP examines the adequacy of SES AI Corporation's (NYSE: SES) risk disclosures during the Class Period of January 29, 2025 through March 4, 2026. A securities class action has been filed on behalf of investors who suffered losses. Find out if you qualify to recover losses from inadequate disclosures. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. SES shares collapsed $0.63 per share, or 36.8%, closing at $...

IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors that Stephan Winckels, Chief Medical Officer of Immutep Limited (NASDAQ: IMMP), is named as an individual defendant in a securities class action filed on behalf of shareholders who purchased ADRs between March 24, 2025 and March 12, 2026. Find out if you qualify to recover losses from the IMMP class action. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.Immutep ADRs lost approximately...
Back to Newsroom